caffeic acid phenethyl ester has been researched along with sevoflurane in 1 studies
| Studies (caffeic acid phenethyl ester) | Trials (caffeic acid phenethyl ester) | Recent Studies (post-2010) (caffeic acid phenethyl ester) | Studies (sevoflurane) | Trials (sevoflurane) | Recent Studies (post-2010) (sevoflurane) |
|---|---|---|---|---|---|
| 840 | 1 | 469 | 7,131 | 2,150 | 3,238 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Han, YZ; Tang, ZJ; Wang, LY | 1 |
1 other study(ies) available for caffeic acid phenethyl ester and sevoflurane
| Article | Year |
|---|---|
Neuroprotective effects of caffeic acid phenethyl ester against sevoflurane‑induced neuronal degeneration in the hippocampus of neonatal rats involve MAPK and PI3K/Akt signaling pathways.
Topics: Anesthetics, Inhalation; Animals; Animals, Newborn; Caffeic Acids; Female; Hippocampus; MAP Kinase Signaling System; Methyl Ethers; Neurodegenerative Diseases; Neuroprotective Agents; Phenylethyl Alcohol; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Sevoflurane; Signal Transduction | 2016 |